Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 43 Records) |
| Query Trace: Neoplasms and UGT1A[original query] |
|---|
| UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population. PloS one 2012 7 (8): e42873. Kua Ley-Fang, Ross Soo, Lee Soo-Chin, Mimura Kousaku, Kono Koji, Goh Boon-Cher, Yong Wei-Pe |
| Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer. Carcinogenesis 2012 Jul 33 (7): 1332-9. Gilsing Anne M J, Berndt Sonja I, Ruder Elizabeth H, Graubard Barry I, Ferrucci Leah M, Burdett Laura, Weissfeld Joel L, Cross Amanda J, Sinha Rash |
| Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Archives of toxicology 2012 Sep 86 (9): 1369-78. Selinski Silvia, Lehmann Marie-Louise, Blaszkewicz Meinolf, Ovsiannikov Daniel, Moormann Oliver, Guballa Christoph, Kress Alexander, Truss Michael C, Gerullis Holger, Otto Thomas, Barski Dimitri, Niegisch Günter, Albers Peter, Frees Sebastian, Brenner Walburgis, Thüroff Joachim W, Angeli-Greaves Miriam, Seidel Thilo, Roth Gerhard, Volkert Frank, Ebbinghaus Rainer, Prager Hans M, Bolt Hermann M, Falkenstein Michael, Zimmermann Anna, Klein Torsten, Reckwitz Thomas, Roemer Hermann C, Hartel Mark, Weistenhöfer Wobbeke, Schöps Wolfgang, Rizvi S Adibul Hassan, Aslam Muhammad, Bánfi Gergely, Romics Imre, Ickstadt Katja, Hengstler Jan G, Golka Kla |
| Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans. Human genetics 2013 Feb 132 (2): 147-58. Jacobs Leonie C, Wollstein Andreas, Lao Oscar, Hofman Albert, Klaver Caroline C, Uitterlinden André G, Nijsten Tamar, Kayser Manfred, Liu F |
| Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Human molecular genetics 2012 Apr 21 (8): 1918-30. Tang Wei, Fu Yi-Ping, Figueroa Jonine D, Malats Núria, Garcia-Closas Montserrat, Chatterjee Nilanjan, Kogevinas Manolis, Baris Dalsu, Thun Michael, Hall Jennifer L, De Vivo Immaculata, Albanes Demetrius, Porter-Gill Patricia, Purdue Mark P, Burdett Laurie, Liu Luyang, Hutchinson Amy, Myers Timothy, Tardón Adonina, Serra Consol, Carrato Alfredo, Garcia-Closas Reina, Lloreta Josep, Johnson Alison, Schwenn Molly, Karagas Margaret R, Schned Alan, Black Amanda, Jacobs Eric J, Diver W Ryan, Gapstur Susan M, Virtamo Jarmo, Hunter David J, Fraumeni Joseph F, Chanock Stephen J, Silverman Debra T, Rothman Nathaniel, Prokunina-Olsson Ludmi |
| UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. Cancer science 2013 Dec 104 (12): 1662-9. Hazama Shoichi, Mishima Hideyuki, Tsunedomi Ryouichi, Okuyama Yusuke, Kato Takeshi, Takahashi Ken-ichi, Nozawa Hiroshi, Ando Hideaki, Kobayashi Michiya, Takemoto Hiroyoshi, Nagata Naoki, Kanekiyo Shinsuke, Inoue Yuka, Hamamoto Yoshihiko, Fujita Yusuke, Hinoda Yuji, Okayama Naoko, Oba Koji, Sakamoto Jun-ichi, Oka Masaa |
| Pharmacogenetic study of deferasirox, an iron chelating agent. PloS one 2013 8 (5): e64114. Lee Ji Won, Kang Hyoung Jin, Choi Ji-Yeob, Kim Nam Hee, Jang Mi Kyung, Yeo Chang-Woo, Lee Sang Seop, Kim Hyery, Park June Dong, Park Kyung Duk, Shin Hee Young, Shin Jae-Gook, Ahn Hyo Se |
| Polymorphic expression of UDP-glucuronosyltransferase UGTlA gene in human colorectal cancer. PloS one 2013 8 (2): e57045. Wang Min, Sun De-Feng, Wang Shuai, Qing Ying, Chen Shuo, Wu Dong, Lin Ying-Min, Luo Ji-Zhuang, Li Yan-Qi |
| Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens. The Journal of pharmacology and experimental therapeutics 2013 Apr 345 (1): 95-101. Lévesque Eric, Bélanger Anne-Sophie, Harvey Mario, Couture Félix, Jonker Derek, Innocenti Federico, Cecchin Erica, Toffoli Giuseppe, Guillemette Chant |
| Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy. The Tohoku journal of experimental medicine 2013 229 (2): 107-14. Inoue Kazuyuki, Sonobe Momoyo, Kawamura Yukinori, Etoh Takashi, Takagi Masakazu, Matsumura Takashi, Kikuyama Masataka, Kimura Midori, Minami Sato, Utsuki Hiroaki, Yamazaki Tomoaki, Suzuki Takayo, Tsuji Daiki, Hayashi Hideki, Itoh Kunihi |
| A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes. International journal of oncology 2014 Oct 45 (4): 1381-90. Tsunedomi Ryouichi, Hazama Shoichi, Fujita Yusuke, Okayama Naoko, Kanekiyo Shinsuke, Inoue Yuka, Yoshino Shigefumi, Yamasaki Takahiro, Suehiro Yutaka, Oba Koji, Mishima Hideyuki, Sakamoto Junichi, Hamamoto Yoshihiko, Oka Masaa |
| Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. British journal of clinical pharmacology 2014 Nov 78 (5): 1067-75. Santoro Ana B, Vargens Daniela D, Barros Filho Mateus de Camargo, Bulzico Daniel A, Kowalski Luiz Paulo, Meirelles Ricardo M R, Paula Daniela P, Neves Ronaldo R S, Pessoa Cencita N, Struchine Claudio J, Suarez-Kurtz Guilher |
| The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions. Genes, chromosomes & cancer 2014 Jun 53 (6): 454-66. Angstadt Andrea Y, Hartman Terryl J, Lesko Samuel M, Muscat Joshua E, Zhu Junjia, Gallagher Carla J, Lazarus Phil |
| UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Jan 24 (1): 94-104. Wassenaar Catherine A, Conti David V, Das Soma, Chen Peixian, Cook Edwin H, Ratain Mark J, Benowitz Neal L, Tyndale Rachel |
| Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms. Journal of the National Cancer Institute 2015 Nov 107 (11): . Figueroa Jonine D, Koutros Stella, Colt Joanne S, Kogevinas Manolis, Garcia-Closas Montserrat, Real Francisco X, Friesen Melissa C, Baris Dalsu, Stewart Patricia, Schwenn Molly, Johnson Alison, Karagas Margaret R, Armenti Karla R, Moore Lee E, Schned Alan, Lenz Petra, Prokunina-Olsson Ludmila, Banday A Rouf, Paquin Ashley, Ylaya Kris, Chung Joon-Yong, Hewitt Stephen M, Nickerson Michael L, Tardón Adonina, Serra Consol, Carrato Alfredo, García-Closas Reina, Lloreta Josep, Malats Núria, Fraumeni Joseph F, Chanock Stephen J, Chatterjee Nilanjan, Rothman Nathaniel, Silverman Debra |
| Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer. Cell biology and toxicology 2016 Jun . Bao Lianmin, Zhang Yong, Wang Jian, Wang Haiyun, Dong Nian, Su Xiaoqiong, Xu Menglin, Wang Xiangdo |
| Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A). Thoracic cancer 2017 Jan 8 (1): 40-45. Fukuda Minoru, Shimada Midori, Kitazaki Takeshi, Nagashima Seiji, Hashiguchi Kohji, Ebi Noriyuki, Takayama Koichi, Nakanishi Yoichi, Semba Hiroshi, Harada Taishi, Seto Takashi, Okamoto Isamu, Ichinose Yukito, Sugio Ken |
| Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis. Journal of toxicology and environmental health. Part A 2017 Jul 1-14. Lukas Cordula, Selinski Silvia, Prager Hans-Martin, Blaszkewicz Meinolf, Hengstler Jan G, Golka Kla |
| Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis. BMC cancer 2017 Jun 17 (1): 437. Liu Dan, Li Jian, Gao Jing, Li Yanyan, Yang Rui, Shen L |
| UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis. Cancer chemotherapy and pharmacology 2017 Jun 79 (6): 1109-1117. Chen Xuewei, Liu Liping, Guo Zhihua, Liang Wenhua, He Jiaxi, Huang Liyan, Deng Qiuhua, Tang Hailing, Pan Hui, Guo Minzhang, Liu Yang, He Qihua, He Jianxi |
| Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer. Carcinogenesis 2017 Sep . Selinski Silvia, Blaszkewicz Meinolf, Ickstadt Katja, Gerullis Holger, Otto Thomas, Roth Emanuel, Volkert Frank, Ovsiannikov Daniel, Moormann Oliver, Banfi Gergely, Nyirady Peter, Vermeulen Sita H, Garcia-Closas Montserrat, Figueroa Jonine D, Johnson Alison, Karagas Margaret R, Kogevinas Manolis, Malats Nuria, Schwenn Molly, Silverman Debra T, Koutros Stella, Rothman Nathaniel, Kiemeney Lambertus A, Hengstler Jan G, Golka Kla |
| Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial. European journal of cancer (Oxford, England : 1990) 2018 Jun 99 66-77. Tejpar Sabine, Yan Pu, Piessevaux Hubert, Dietrich Daniel, Brauchli Peter, Klingbiel Dirk, Fiocca Roberto, Delorenzi Mauro, Bosman Fred, Roth Arnaud |
| Bladder Cancer Genetic Susceptibility. A Systematic Review. Bladder cancer (Amsterdam, Netherlands) 2018 Apr 4 (2): 215-226. de Maturana Evangelina López, Rava Marta, Anumudu Chiaka, Sáez Olga, Alonso Dolores, Malats Núr |
| UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy. Cancer chemotherapy and pharmacology 2018 May . Yu Qianqian, Zhang Tao, Xie Conghua, Qiu Hong, Liu Bo, Huang Liu, Peng Ping, Feng Jueping, Chen Jigui, Zang Aihua, Yuan Xiangl |
| Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity. Medicina clinica 2018 Feb . García Gil Sara, Ramos Díaz Ruth, Nazco Casariego Gloria Julia, Llanos Muñoz Marta, Viña Romero Maria Micaela, Martín Calero Braulio, Pérez Pérez Jose Antonio, Gutiérrez Nicolás Fernan |
| Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype. British journal of cancer 2019 Jan 120 (2): 190-195. Páez David, Tobeña María, Fernández-Plana Julen, Sebio Ana, Virgili Anna C, Cirera Lluís, Barnadas Agustí, Riera Pau, Sullivan Ivana, Salazar Julia |
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.
Cancer medicine 2019 Apr . Grant Delores J, Manichaikul Ani, Alberg Anthony J, Bandera Elisa V, Barnholtz-Sloan Jill, Bondy Melissa, Cote Michele L, Funkhouser Ellen, Moorman Patricia G, Peres Lauren C, Peters Edward S, Schwartz Ann G, Terry Paul D, Wang Xin-Qun, Keku Temitope O, Hoyo Cathrine, Berchuck Andrew, Sandler Dale P, Taylor Jack A, O'Brien Katie M, Velez Edwards Digna R, Edwards Todd L, Beeghly-Fadiel Alicia, Wentzensen Nicolas, Pearce Celeste Leigh, Wu Anna H, Whittemore Alice S, McGuire Valerie, Sieh Weiva, Rothstein Joseph H, Modugno Francesmary, Ness Roberta, Moysich Kirsten, Rossing Mary Anne, Doherty Jennifer A, Sellers Thomas A, Permuth-Way Jennifer B, Monteiro Alvaro N, Levine Douglas A, Setiawan Veronica Wendy, Haiman Christopher A, LeMarchand Loic, Wilkens Lynne R, Karlan Beth Y, Menon Usha, Ramus Susan, Gayther Simon, Gentry-Maharaj Aleksandra, Terry Kathryn L, Cramer Daniel W, Goode Ellen L, Larson Melissa C, Kaufmann Scott H, Cannioto Rikki, Odunsi Kunle, Etter John L, Huang Ruea-Yea, Bernardini Marcus Q, Tone Alicia A, May Taymaa, Goodman Marc T, Thompson Pamela J, Carney Michael E, Tworoger Shelley S, Poole Elizabeth M, Lambrechts Diether, Vergote Ignace, Vanderstichele Adriaan, Van Nieuwenhuysen Els, Anton-Culver Hoda, Ziogas Argyrios, Brenton James D, Bjorge Line, Salvensen Helga B, Kiemeney Lambertus A, Massuger Leon F A G, Pejovic Tanja, Bruegl Amanda, Moffitt Melissa, Cook Linda, Le Nhu D, Brooks-Wilson Angela, Kelemen Linda E, Pharoah Paul D P, Song Honglin, Campbell Ian, Eccles Diana, DeFazio Anna, Kennedy Catherine J, Schildkraut Joellen |
| Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity. Cancer medicine 2022 10 . Kanesada Kou, Tsunedomi Ryouichi, Hazama Shoichi, Ogihara Hiroyuki, Hamamoto Yoshihiko, Shindo Yoshitaro, Matsui Hiroto, Tokumitsu Yukio, Yoshida Shin, Iida Michihisa, Suzuki Nobuaki, Takeda Shigeru, Ioka Tatsuya, Nagano Hiroa |
| The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients. Genomics & informatics 2022 Sep 20 (3): e29. Lee Choong-Kun, Chon Hong Jae, Kwon Woo Sun, Ban Hyo-Jeong, Kim Sang Cheol, Kim Hyunwook, Jeung Hei-Cheul, Chung Jimyung, Rha Sun You |
| Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group. Journal of experimental & clinical cancer research : CR 2023 1 42 (1): 21. Junk Stefanie V, Schaeffeler Elke, Zimmermann Martin, Möricke Anja, Beier Rita, Schütte Peter, Fedders Birthe, Alten Julia, Hinze Laura, Klein Norman, Kulozik Andreas, Muckenthaler Martina U, Koehler Rolf, Borkhardt Arndt, Vijayakrishnan Jayaram, Ellinghaus David, Forster Michael, Franke Andre, Wintering Astrid, Kratz Christian P, Schrappe Martin, Schwab Matthias, Houlston Richard S, Cario Gunnar, Stanulla Mart |
- Page last reviewed:Feb 1, 2024
- Content source: